Skip to main content

Vandervoort Adam C's Form 4 filing

Teladoc Health, Inc. (TDOC) · filed Mar 4, 2025

Accession no.
0001477449-25-000016
Filed
Mar 4, 2025
Trade date
Feb 28-Mar 3, 2025
Filing delay
4 days
Rule 10b5-1 plan
Not checked

This filing lists 4 non-derivative transactions and 4 derivative transactions. Open-market sales total $38.1K. It was filed 4 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Vandervoort Adam CCIK 0001375088Officer (CHIEF LEGAL OFFICER, SECRETARY)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Feb 28, 2025Common StockMOption exerciseAcquired+1,881–F1–51,931Direct
–Common StockMOption exerciseAcquired+4,418–F1–56,349DirectInvalid date
Feb 28, 2025Common StockMOption exerciseAcquired+1,505–F2–57,854Direct
Mar 3, 2025Common StockSSaleDisposed−3,935$9.68−$38,090.853,919Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Feb 28, 2025Common StockMOption exerciseDisposed−1,881$0.00$00Direct
Feb 28, 2025Common StockMOption exerciseDisposed−4,418$0.00$017,672Direct
Feb 28, 2025Common StockMOption exerciseDisposed−1,505$0.00$06,025Direct
Mar 1, 2025Common StockAGrant or awardAcquired+109,832$0.00$0109,832Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.

Referenced by the price of 2 transactions in Table I.

F2

Performance stock units convert to shares of TDOC common stock on a one-for-one basis.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)